Delivery Order SPE2DB24D1205-SPE2DB25FCXWY

Award Date 6/20/25
Potential Completion Date 6/23/25
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,219.60 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The award is for the supply of KLOR-CON M20 TABLET 100S, a pharmaceutical product, with an ultimate completion date of November 6, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,933.93 firm fixed-price contract is for the delivery of KLOR-CON M20 TABLET 500S, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KLOR-CON M20 tablets. The contract has a ceiling value of $2,750.78 and an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,235.67, is for the delivery of KLOR-CON M20 TABLET 500S, a pharmaceutical product. The contract is a Firm Fixed Price type with an ultimate completion date of June 24, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery...
This federal contract award, with a GovTribe ID of SPE2DB20D1004|SPE2DB25FNGVS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.93 firm fixed-price delivery order is for the supply of KLOR-CON M20 TABLET 500S, a medication used for the treatment of various medical conditions. The contract has an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $17,863.71, and has an ultimate completion date of July 1, 2025. The contract covers the supply of pharmaceutical products, medical devices, and other healthcare-related supplies to support military and government healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of pharmaceutical products, valued at $1,811.35, with a performance period ending on June 13, 2025. The contract is a firm fixed-price, non-set-aside vehicle, allowing for open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the U.S. Defense Logistics Agency (DLA). The $48,301.28 firm-fixed-price delivery order contract has an ultimate completion date of May 20, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on June 5, 2025. The $10,909.12 contract provides a range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,136.97 with a completion date of July 16, 2024. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCXWY
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a $6,498.70 firm fixed price delivery order for the supply of KLOR-CON M20 TABLET 500S, a pharmaceutical product. The contract has a completion date of June 23, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The contract award described is not designated as a set-aside.

Generated 9/19/25, 10:44 AM